C83.7
Burkitt lymphoma
Clinical Classification Guidelines
Inclusion Terms
- Atypical Burkitt lymphoma
- Burkitt-like lymphoma
Excludes Type 1
- mature B-cell leukemia Burkitt type (C91.A-)
Medical Intelligence & Overview
Burkitt lymphoma is a highly aggressive form of non-Hodgkin lymphoma that originates from B-lymphocytes, a type of white blood cell. Characterized by rapid growth, it can quickly spread to other parts of the body if not diagnosed and treated promptly. Although less common than other lymphomas, understanding its features can help in early recognition and management.
Causes & Symptoms
Clinical Causes: Infection with the Epstein-Barr virus (EBV), especially in endemic regions. Genetic factors and chromosomal translocations involving the MYC gene, which leads to uncontrolled cell growth. Immunodeficiency conditions, such as HIV/AIDS or immune-suppressing therapies post-transplant. Certain environmental exposures, although these are less clearly defined.
Key Symptoms: Rapidly enlarging lymph nodes, often in the abdomen or neck. B symptoms such as fever, night sweats, and unexplained weight loss. Abdominal pain or swelling due to tumor masses in the stomach or intestines. Fatigue and general weakness. Possible involvement of the central nervous system, leading to neurological symptoms.
Diagnostic & Treatment
Diagnosis Path: Diagnosing Burkitt lymphoma involves a combination of medical history, physical examination, and diagnostic tests. These may include:
Treatment Protocols: Treatment strategies for Burkitt lymphoma generally involve intensive chemotherapy regimens aimed at quickly reducing tumor burden. Management may include:
Clinical Advice & FAQs
Billing Guidance
Is C83.7 a billable ICD-10 code?
Yes, C83.7 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C83.7?
Clinical documentation must specify the nature of Burkitt lymphoma and any associated comorbidities for accurate reporting.
Cite this Clinical Reference